DH SHEPP, BA NEWTON, PS DANDLIKER, … - Annals of internal …, 1985 - Am Coll Physicians In a randomized, double-blinded, placebo-controlled trial, we compared the therapeutic effect
of oral acyclovir (400 mg five times daily for 10 days) with that of placebo in patients with marrow
transplants and culture-proven recurrent mucocutaneous herpes simplex. Twelve patients ... Cited by 82 - Related articles - All 3 versions
JC WADE, B NEWTON, N FLOURNOY, JD … - Annals of internal …, 1984 - Am Coll Physicians Oral acyclovir was found to be safe and effective for the prevention of herpes simplex virus reactivation
after marrow transplantation in a double-blind, placebo-controlled trial. Acyclovir or placebo was
administered to 49 patients for 5 weeks beginning 1 week before transplantation: 5 of 24 ... Cited by 173 - Related articles - All 3 versions
RJ Whitley, M Levin, N Barton, BJ Hershey, G Davis … - The Journal of infectious …, 1984 - jstor.org THE JOURNAL OF INFECTIOUS DISEASES . VOL. 150, NO. 3 . SEPTEMBER 1984 (c) 1984
by The University of Chicago. All rights reserved. 0022-1899/84/5003-0002$01.00 ... Infections
Caused by Herpes Simplex Virus in the Immunocompromised Host: Cited by 71 - Related articles - All 3 versions
IM Hann, HG Prentice, HA Blacklock, MG Ross, D … - British Medical Journal, 1983 - bmj.com Twenty patients undergoing allogeneic bone marrow transplantation and 39 patients receiving
remission induction chemotherapy for acute leukaemia were entered into a double blind, placebo
controlled stratified trial of acyclovir prophylaxis against herpes group virus infections. ... Cited by 82 - Related articles - All 4 versions
SE STRAUS, M SEIDLIN, H TAKIFF, D … - Annals of internal …, 1984 - Am Coll Physicians Thirty-two episodes of herpes simplex virus infection in four immunodeficient patients with frequent
recurrences were successfully treated with oral acyclovir, one capsule five times a day for 5
days. In 23 of these episodes, the treatments were extended for 1 to 6 months using two ... Cited by 80 - Related articles - All 3 versions
R SARAL, RF AMBINDER, WH BURNS, CM … - Annals of internal …, 1983 - Am Coll Physicians Twenty-nine adult patients with acute leukemia receiving timed sequential chemotherapy participated
in a randomized, double-blind, placebo-controlled trial of acyclovir prophylaxis against reactivated
herpes simplex virus infection. Patients with pretreatment antibody titers of 1:16 or greater ... Cited by 81 - Related articles - All 4 versions
JC Wade, C McLaren, JD Meyers - The Journal of infectious diseases, 1983 - jstor.org THE JOURNAL OF INFECTIOUS DISEASES - VOL. 148, NO. 6 - DECEMBER 1983 (c) 1983
by The University of Chicago. All rights reserved. 0022-1899/83/4806-0014$00.75 ... Frequency
and Significance of Acyclovir-Resistant Herpes Simplex Virus Isolated Cited by 111 - Related articles - All 3 versions
JD Meyers, JC Wade, CD Mitchell, R Saral, … - The American journal of …, 1982 - ncbi.nlm.nih.gov Intravenous acyclovir was evaluated in the treatment of 97 immunocompromised patients with
mucocutaneous herpes simplex virus infection in a randomized, double-blind, placebo-controlled
trial. Acyclovir recipients had significantly shorter periods of virus shedding (p less than ... Cited by 166 - Related articles
RJ Whitley, S Spruance, FG Hayden, J Overall, CA … - The Journal of infectious …, 1984 - jstor.org THE JOURNAL OF INFECTIOUS DISEASES * VOL. 149, NO. 1 * JANUARY 1984 ... @ 1984
by The University of Chicago. All rights reserved. 0022-1899/84/4901-0001$00.81 ... Vidarabine
Therapy for Mucocutaneous Herpes Simplex Virus Infections ... RJ Whitley, S. Spruance, ... Cited by 18 - Related articles - All 3 versions
JC WADE, B NEWTON, C McLAREN, N … - Annals of Internal …, 1982 - Am Coll Physicians Acyclovir, a new antiviral agent, was compared to a placebo in a randomized double-blind trial
of treatment for culture-proven herpes simplex virus infection after marrow transplantation. Patients
received either intravenous acyclovir at 750 mg/m 2 body surface area per day or a ... Cited by 198 - Related articles - All 2 versions